Amlodipine is a long-acting calcium channel blocker used for the management of canine chronic renal disease.
This drug increases forward flow with afterload reduction because of the reduction in systemic vascular resistance, thereby allowing its use in the management of mitral valve endocardiosis, hypertrophic cardiomyopathy, atrial fibrillation and systemic hypertension.
Recommended dose in dogs is 0.2 mg/kg twice daily per os.
- Strickland KN (2008) In: Manual of Canine and Feline Cardiology. 4. Tilley LP, Smith FWK Jr, Oyama MA, Sleeper MM, editor. Philadelphia: Saunders. Pathophysiology and Therapy of Heart Failure; pp:288–314
- Bright JM et al (1991) Evaluation of the calcium channel-blocking agents diltiazem and verapamil for treatment of feline hypertrophic cardiomyopathy. J Vet Intern Med 5(5):272–282
- Miyamoto M et al (2001) Acute cardiovascular effects of diltiazem in anesthetized dogs with induced atrial fibrillation. J Vet Intern Med 15(6):559–563
- Snyder PS et al (2001) Effect of amlodipine on echocardiographic variables in cats with systemic hypertension. J Vet Intern Med 15(1):52–56
- Suzuki S et al (2012) Long-term tolerability of benazepril in dogs with congestive heart failure. J Vet Cardiol 6(1):7-13